Equity
Investments - Gross Unrealized Losses
Edwards Lifesciences Investments - Gross Unrealized Losses increased by 222.2% to $488.5M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 216.4%, from $154.4M to $488.5M. Over 4 years (FY 2021 to FY 2025), Investments - Gross Unrealized Losses shows a downward trend with a -44.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2017
Last reportedQ1 2026May 6, 2026
Metric ID:
investments_gross_unrealized_lossesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $382M | $582.7M | $1.63B | $1.67B | $1.62B | $1.63B | $1.47B | $1.29B | $1.17B | $974.8M | $878.9M | $634.3M | $437.8M | $298.6M | $222.6M | $154.4M | $125.6M | $101.7M | $151.6M | $488.5M |
| QoQ Change | — | +52.5% | +180.2% | +2.3% | -2.8% | +0.7% | -10.4% | -11.8% | -9.6% | -16.5% | -9.8% | -27.8% | -31.0% | -31.8% | -25.5% | -30.6% | -18.7% | -19.0% | +49.1% | +222.2% |
| YoY Change | — | — | — | — | +324.9% | +180.6% | -10.2% | -22.7% | -28.1% | -40.4% | -40.0% | -50.9% | -62.5% | -69.4% | -74.7% | -75.7% | -71.3% | -65.9% | -31.9% | +216.4% |
Range$101.7M – $1.67B
CAGR+5.3%
Avg YoY Growth+4.9%
Median YoY Growth-40.2%
Current Streak2 quarters growth
Frequently Asked Questions
- What is Edwards Lifesciences's investments - gross unrealized losses?
- Edwards Lifesciences (EW) reported investments - gross unrealized losses of $488.5M in Q1 2026.
- How has Edwards Lifesciences's investments - gross unrealized losses changed year-over-year?
- Edwards Lifesciences's investments - gross unrealized losses increased by 216.4% year-over-year, from $154.4M to $488.5M.
- What is the long-term trend for Edwards Lifesciences's investments - gross unrealized losses?
- Over 4 years (2021 to 2025), Edwards Lifesciences's investments - gross unrealized losses has grown at a -44.8% compound annual growth rate (CAGR), from $1.63B to $151.6M.